MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2643.92%
Quick Ratio
2643.92%
Debt to Asset Ratio
10.57%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Revenue share liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
105,571
451,797
131,549
107,914
Marketable securities
866,355
608,088
598,643
419,375
Prepaid expenses and other current assets
19,807
13,912
11,166
12,808
Total current assets
991,733
1,073,797
741,358
540,097
Long-term marketable securities
321,943
198,354
172,730
61,640
Property and equipment, net
4,822
5,280
5,688
6,032
Right-of-use asset, net
6,708
7,707
8,687
9,646
Other non-current assets
10,607
8,516
8,671
8,744
Total assets
1,335,813
1,293,654
937,134
626,159
Accounts payable
3,080
1,237
1,221
376
Lease liability
2,365
3,138
3,504
4,079
Accrued expenses and other current liabilities
32,065
28,577
23,181
29,592
Total current liabilities
37,510
32,952
27,906
34,047
Lease liability, net of current
4,468
4,909
5,345
5,774
Revenue share liability
99,231
-
-
-
Total liabilities
141,209
37,861
33,251
39,821
Common stock 0.00001 par value, 400,000,000 authorized, 75,611,894 issued and 75,339,499 outstanding as of june 30, 2026 400,000,000 authorized, 69,038,943 issued and 68,401,349 outstanding as of december 31, 2025
1
1
1
1
Additional paid-in capital
1,918,830
1,892,411
1,464,561
1,077,681
Accumulated other comprehensive (loss) income
-2,503
-749
1,080
1,028
Accumulated deficit
-721,724
-635,870
-561,759
-492,372
Total stockholders' equity
1,194,604
1,255,793
903,883
586,338
Total liabilities and stockholders' equity
1,335,813
1,293,654
937,134
626,159
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$866,355K (127.25%↑ Y/Y)Cash and cashequivalents$105,571K (-14.99%↓ Y/Y)Prepaid expenses andother current assets$19,807K (85.08%↑ Y/Y)Total current assets$991,733K (92.15%↑ Y/Y)Long-term marketablesecurities$321,943K (178.09%↑ Y/Y)Other non-currentassets$10,607K (19.76%↑ Y/Y)Right-of-use asset, net$6,708K (-36.63%↓ Y/Y)Property and equipment,net$4,822K (-25.10%↓ Y/Y)Total assets$1,335,813K (103.08%↑ Y/Y)Total liabilities andstockholders' equity$1,335,813K (103.08%↑ Y/Y)Total stockholders'equity$1,194,604K (92.86%↑ Y/Y)Total liabilities$141,209K (268.01%↑ Y/Y)Accumulated deficit-$721,724K (-68.88%↓ Y/Y)Accumulated othercomprehensive (loss) income-$2,503K (-465.40%↓ Y/Y)Additional paid-in capital$1,918,830K (83.43%↑ Y/Y)Revenue share liability$99,231K Total currentliabilities$37,510K (18.89%↑ Y/Y)Lease liability, netof current$4,468K (-34.49%↓ Y/Y)Common stock 0.00001par value,...$1K (0.00%↑ Y/Y)Accrued expenses andother current...$32,065K (46.76%↑ Y/Y)Accounts payable$3,080K (-45.76%↓ Y/Y)Lease liability$2,365K (-41.24%↓ Y/Y)

Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. (APGE)